Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02336945 · ClinicalTrials.gov registry record
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional
A clinical trial, sponsored by Abbott Diabetes Care.
- Completed
- Registry status
- 146
- Enrollment target
NCT02336945: Completed study, sponsored by Abbott Diabetes Care.
NCT02336945 is a clinical trial that has completed, run by Abbott Diabetes Care. The registered enrollment target is 146 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02336945 has completed, sponsored by Abbott Diabetes Care.
- COMPLETED
- Registry status
- 146 participants
- Enrollment target
Study Summary
This is a multi-center, prospective, non-pivotal, single arm, non-significant risk evaluation the Abbott Sensor Based Glucose Monitoring System - Pro across different stages of T2 diabetes management. This is a non-significant risk study.
Interventions
- DEVICE Abbott Sensor Based Glucose Monitoring System-Professional
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2015-01 |
| Est. Completion | 2015-07 |
What the finished NCT02336945 record still lists
NCT02336945 is an observational study that tracks outcomes without assigning an intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Abbott Sensor Based Glucose Monitoring System-Professional is the first listed.
NCT02336945 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02336945 about?
NCT02336945 is a clinical study titled "Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional". This is a multi-center, prospective, non-pivotal, single arm, non-significant risk evaluation the Abbott Sensor Based Glucose Monitoring System - Pro across different stages of T2 diabetes management. This is a non-significant risk study.
What is the current status of trial NCT02336945?
This trial is currently completed. The enrollment target is 146 participants. The study started on 2015-01. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02336945?
The interventions under investigation include: Abbott Sensor Based Glucose Monitoring System-Professional (DEVICE).
Who is sponsoring clinical trial NCT02336945?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia